Research Our Research Activities. Our Research Publications. Updated August Keyword search. J Thromb Haemost. Health care providers. Benchmarking and standard setting. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia. View A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
Basic research. Maximum hour platelet count fall: Metric for improving the diagnosis of heparin-induced thrombocytopenia among patients with intermediate probability 4Ts scores.
View Maximum hour platelet count fall: Metric for improving the diagnosis of heparin-induced thrombocytopenia among patients with intermediate probability 4Ts scores. New or improved product or process. A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins.
View A prospective study measuring the development of antibodies against platelet factor 4-heparin in healthy males after exposure to heparins. Clinical research. Autoimmune heparin-induced thrombocytopenia. View Autoimmune heparin-induced thrombocytopenia. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. View Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. View ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. Platelet-activating immune complexes identified in critically ill COVID patients suspected of heparin-induced thrombocytopenia. View Platelet-activating immune complexes identified in critically ill COVID patients suspected of heparin-induced thrombocytopenia.
